Skip to main content

Atopic Dermatitis and Chinese Medicine

  • Protocol
  • First Online:

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

Abstract

Atopic dermatitis (AD) is said to be the most common skin disease among children, which impacts severely on daily life. The etiology has yet to be fully elucidated and current western medicine managements are targeted at symptomatic relief, some of which have unfavorable side effects. According to the traditional Chinese medicine (TCM), AD is said to be related to a congenitally weak constitution, leading to the attack or generation of pathogenic factors. Chinese herbal medicine (CHM) is usually individualized for each and every patient; however, in hope of increasing the scientific evidence of its efficacy and safety in the treatment of AD, several clinical trials have been conducted using non-individualized CHM.

This chapter reviews the findings of clinical and laboratory studies of 4 CHM formulae: Zemaphyte, Pentaherbs Capsule, Hochu-ekki-to, and Xiao Feng San. In clinical studies, Zemaphyte had conflicting results, Pentaherb Capsule and Hochu-ekki-to showed no significant difference in disease severity but found improvement in secondary outcomes, and Xiao Feng San had positive results. All in-vitro studies found potential pharmacological effects that may be beneficial in the management of AD. However, aside from evidence still being deemed insufficient, there were one or more flaws in the clinical study designs, leading to concerns of the credibility of the results. The main concerns identified with studies included the general quality of studies, the suitability of the using a scientific, randomized, control methodology for TCM studies, the lack of pharmacological data of CHM, and the lack of assurance regarding the safety of the intervention. Currently, the treatment of AD with TCM is still highly based on historical and empirical evidence; and as the complete pathophysiology of AD remains unknown, it may be difficult to determine which biochemical and pharmacological properties are required in the CHM to allow it to be deemed a potential pharmacotherapy

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Zhang W, Leonard T, Bath-Hextall F, Chambers CA, Lee C, Humphreys R, Williams Hywel C (2004) Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev (4). doi: 10.1002/14651858.CD002291

    Google Scholar 

  2. Bieber T (2008) Atopic dermatitis. N Engl J Med 358(14):1483–1494. doi:10.1056/NEJMra074081

    Article  CAS  PubMed  Google Scholar 

  3. Buys LM (2007) Treatment options for atopic dermatitis. Am Fam Physician 75(4):523

    PubMed  Google Scholar 

  4. Möhrenschlager M, Darsow U, Schnopp C, Ring J (2006) Atopic eczema: what’s new? J Eur Acad Dermatol Venereol 20(5):503–513. doi:10.1111/j.1468-3083.2006.01580.x

    Article  PubMed  Google Scholar 

  5. Sandstrom Falk MH, Faergemann J (2006) Atopic dermatitis in adults: does it disappear with age? Acta Derm Venereol 86(2):135–139. doi:10.2340/00015555-0040

    PubMed  Google Scholar 

  6. Baron SE, Cohen SN, Archer CB (2012) Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol 37(suppl 1):7–12. doi:10.1111/j.1365-2230.2012.04336.x

    Google Scholar 

  7. Coca AF, Cooke RA (1923) On the classification of the phenomena of hypersensitiveness. J Immunol 8(3):163–182

    CAS  Google Scholar 

  8. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TAE, Ring J, Thien F, Van Cauwenberge P, Williams HC (2004) Revised nomenclature for allergy for global use: report of the nomenclature review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113(5):832–836

    Article  CAS  PubMed  Google Scholar 

  9. Hanifin JM (2012) Atopic dermatitis nomenclature variants can impede harmonization. J Invest Dermatol 132(2):472–473

    Article  CAS  PubMed  Google Scholar 

  10. Schmitt J, Flohr C, Williams HC (2012) Outcome measures, case definition, and nomenclature are all important and distinct aspects of atopic eczema: a call for harmonization. J Invest Dermatol 132(2):473–474

    Article  CAS  Google Scholar 

  11. Chang C, Keen CL, Gershwin ME (2007) Treatment of eczema. Clin Rev Allergy Immunol 33(3):204–225. doi:10.1007/s12016-007-0033-8

    Article  CAS  PubMed  Google Scholar 

  12. Feingold S, Huang C, Kristal L, Kalish R, Clark RAF (1998) Eczemas. Curr Probl Dermatol 10(2):41–90. doi:10.1016/s1040-0486(98)90008-4

    Article  Google Scholar 

  13. Williams HC, Burney PGJ, Hay RJ, Archer CB, Shipley MJ, Hunter JJA, Bingham EA, Finlay AY, Pembroke AC, Grahambrown RAC, Atherton DA, Lewisjones MS, Holden CA, Harper JI, Champion RH, Poyner TF, Launer J, David TJ (1994) The UK working party diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 131(3):383–396. doi:10.1111/j.1365-2133.1994.tb08530.x

    Article  CAS  PubMed  Google Scholar 

  14. Hoare C, Li Wan Po A, Williams H (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4(37)

    Google Scholar 

  15. Ring J, Przybilla B, Ruzicka T (2006) Handbook of atopic eczema. Springer Verlag, New York

    Book  Google Scholar 

  16. Schultz Larsen F, Holm NV, Henningsen K (1986) Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 15(3):487–494

    Article  Google Scholar 

  17. Dold S, Wjst M, Von Mutius E, Reitmeir P, Stiepel E (1992) Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 67(8):1018–1022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Brown S, Reynolds NJ (2006) Atopic and non-atopic eczema. Br Med J 332(7541):584–588

    Article  Google Scholar 

  19. Weidinger S, Illig T, Baurecht H, Irvine AD, Rodriguez E, Diaz-Lacava A, Klopp N, Wagenpfeil S, Zhao Y, Liao H, Lee SP, Palmer CNA, Jenneck C, Maintz L, Hagemann T, Behrendt H, Ring J, Nothen MM, McLean WHI, Novak N (2006) Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 118(1):214–219. doi:10.1016/j.jaci.2006.05.004

    Article  CAS  PubMed  Google Scholar 

  20. Hoffjan S, Epplen JT (2005) The genetics of atopic dermatitis: recent findings and future options. J Mol Med 83(9):682–692

    Article  CAS  PubMed  Google Scholar 

  21. Paternoster L, Standl M, Chen CM, Ramasamy A, Bøpnnelykke K, Duijts L, Ferreira MA, Alves AC, Thyssen JP, Albrecht E, Baurecht H, Feenstra B, Sleiman PMA, Hysi P, Warrington NM, Curjuric I, Myhre R, Curtin JA, Groen-Blokhuis MM, Kerkhof M, Sääf A, Franke A, Ellinghaus D, Fölster-Holst R, Dermitzakis E, Montgomery SB, Prokisch H, Heim K, Hartikainen AL, Pouta A, Pekkanen J, Blakemore AIF, Buxton JL, Kaakinen M, Duffy DL, Madden PA, Heath AC, Montgomery GW, Thompson PJ, Matheson MC, Le Souëf P, Pourcain BS, Smith GD, Henderson J, Kemp JP, Timpson NJ, Deloukas P, Ring SM, Wichmann HE, Müller-Nurasyid M, Novak N, Klopp N, Rodríguez E, McArdle W, Linneberg A, Menné T, Nohr EA, Hofman A, Uitterlinden AG, Van Duijn CM, Rivadeneira F, De Jongste JC, Van Der Valk RJP, Wjst M, Jogi R, Geller F, Boyd HA, Murray JC, Kim C, Mentch F, March M, Mangino M, Spector TD, Bataille V, Pennell CE, Holt PG, Sly P, Tiesler CMT, Thiering E, Illig T, Imboden M, Nystad W, Simpson A, Hottenga JJ, Postma D, Koppelman GH, Smit HA, Söderhäll C, Chawes B, Kreiner-Møpller E, Bisgaard H, Melén E, Boomsma DI, Custovic A, Jacobsson B, Probst-Hensch NM, Palmer LJ, Glass D, Hakonarson H, Melbye M, Jarvis DL, Jaddoe VWV, Gieger C, Strachan DP, Martin NG, Jarvelin MR, Heinrich J, Evans DM, Weidinger S (2012) Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet 44(2):187–192

    Article  CAS  Google Scholar 

  22. Saito H (2005) Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol 137(4):319–325

    Article  CAS  PubMed  Google Scholar 

  23. Martin PE, Koplin JJ, Eckert JK, Lowe AJ, Ponsonby AL, Osborne NJ, Gurrin LC, Robinson MN, Hill DJ, Tang MLK, Dharmage SC, Allen KJ (2013) The prevalence and socio-demographic risk factors of clinical eczema in infancy: a population-based observational study. Clin Exp Allergy 43(6):642–651

    CAS  PubMed  Google Scholar 

  24. Williams HC (2000) Epidemiology of atopic dermatitis. Clin Exp Dermatol 25(7):522–529

    Article  CAS  PubMed  Google Scholar 

  25. Williams HC (2013) Epidemiology of human atopic dermatitis - seven areas of notable progress and seven areas of notable ignorance. Vet Dermatol 24(1):3, e2

    Article  PubMed  Google Scholar 

  26. Strachan DP (1989) Hay fever, hygiene, and household size. Br Med J 299(6710):1259–1260

    Article  CAS  Google Scholar 

  27. Leung TNH, Chow CM, Chow MPY, Luk DCK, Ho KM, Hon KL, Sugunan VK (2013) Clinical guidelines on management of atopic dermatitis in children. Hong Kong J Paediatr 18(2):96–104

    Google Scholar 

  28. Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K (2009) Guidelines for management of atopic dermatitis. J Dermatol 36(10):563–577

    Article  PubMed  Google Scholar 

  29. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) Part I. J Eur Acad Dermatol Venereol 26(8):1045–1060. doi:10.1111/j.1468-3083.2012.04635.x

    Article  CAS  PubMed  Google Scholar 

  30. NICE (2007) Atopic Eczema in children: management of atopic eczema in children from birth up to the age of 12 years. NICE Clinical Guidelines. RCOG Press, London

    Google Scholar 

  31. Hsu C-J, Wang L-F (2007) Emerging treatment of atopic dermatitis. Clin Rev Allergy Immunol 33(3):199–203. doi:10.1007/s12016-007-0043-6

    Article  CAS  PubMed  Google Scholar 

  32. Salameh F, Perla D, Solomon M, Gamus D, Barzilai A, Greenberger S, Trau H (2008) The effectiveness of combined Chinese herbal medicine and acupuncture in the treatment of atopic dermatitis. J Altern Complement Med 14(8):1043–1048. doi:10.1089/acm.2008.0162

    Article  PubMed  Google Scholar 

  33. Bedi MK, Shenefelt PD (2002) Herbal therapy in dermatology. Arch Dermatol 138(2):232–242

    Article  PubMed  Google Scholar 

  34. Kayne SB (2009) Traditional medicine: A global perspective. Pharmaceutical Press, London

    Google Scholar 

  35. Chen D, Lu C (2007) The clinical practice of Chinese medicine: eczema & atopic dermatitis (trans: Wang J, Kurtz A). People’s Medical Publishing House, Beijing

    Google Scholar 

  36. Shen DH, Wu X, Wang N (2007) Manual of dermatology in Chinese medicine. Eastland Press, Seattle, WA

    Google Scholar 

  37. Tan HY, Zhang AL, Xue CC, Chen D, Da Costa C, Lenon GB (2013) Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children. BMJ Open 3(12):e003906. doi:10.1136/bmjopen-2013-003906

    Article  PubMed  PubMed Central  Google Scholar 

  38. State Administration of Traditional Chinese Medicine of the People’s Republic of China (1994) Criteria of diagnosis and therapeutic effect of diseases and syndromes in traditional Chinese medicine, vol ZY/T001.1-94. Chinese Medicine Profession Standards of the People’s Republic of China

    Google Scholar 

  39. Li L, Zhao C (1991) Dermatology. The English-Chinese Encyclopedia of Practical Traditional Chinese Medicine. Higher Education Press, Beijing

    Google Scholar 

  40. Lin L (1995) Practical traditional Chinese dermatology (trans: Tai W), 1st edn. Hai Feng Publishing, Hong Kong

    Google Scholar 

  41. Barnes J (2003) Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I Regulation and quality. Br J Clin Pharmacol 55(3):226–233

    Article  PubMed  PubMed Central  Google Scholar 

  42. Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, Imazu Y, Reissenweber H, Witt CM (2011) Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine - The state of research and methodological suggestions for the future. Evid Based Complement Alternat Med 2011:513842. doi:10.1093/ecam/neq067

    Article  PubMed  PubMed Central  Google Scholar 

  43. Arun G, Chandra K (2012) Evaluation of efficacy and safety of herbal/ayurvedic medicines. In: The Modern Ayurveda. CRC Press, p 317–336. doi:10.1201/b11722-12

    Google Scholar 

  44. Armstrong NC, Ernst E (1999) The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials. Br J Clin Pharmacol 48(2):262–264. doi:10.1046/j.1365-2125.1999.00004.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Gu S, Yang Angela WH, Xue Charlie CL, Li Chun G, Pang C, Zhang W, Williams Hywel C (2013) Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev (9). doi:10.1002/14651858.CD008642.pub2

    Google Scholar 

  46. Tan HY, Zhang AL, Chen D, Xue CC, Lenon GB (2013) Chinese herbal medicine for atopic dermatitis: a systematic review. J Am Acad Dermatol 69(2):295–304

    Article  PubMed  Google Scholar 

  47. Atherton DJ, Sheehan MP, Rustin MHA, Whittle B, Guy G (1992) Treatment of atopic eczema with traditional Chinese medicinal plants. Pediatr Dermatol 9(4):373–375

    Article  CAS  PubMed  Google Scholar 

  48. Sheehan MP, Atherton DJ (1992) A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 126(2):179–184

    Article  CAS  PubMed  Google Scholar 

  49. Fung AYP, Look PCN, Chong LY, But PPH, Wong E (1999) A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 38(5):387–392. doi:10.1046/j.1365-4362.1999.00732.x

    Article  CAS  PubMed  Google Scholar 

  50. Sheehan MP, Rustin MHA, Atherton DJ, Buckley C, Harris DJ, Brostoff J, Ostlere L, Dawson A (1992) Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet 340(8810):13–17

    Article  CAS  PubMed  Google Scholar 

  51. Banerjee P, Xu XJ, Poulter LW, Rustin MHA (1998) Changes in CD23 expression of blood and skin in atopic eczema after Chinese herbal therapy. Clin Exp Allergy 28(3):306–314. doi:10.1046/j.1365-2222.1998.00233.x

    Article  CAS  PubMed  Google Scholar 

  52. Chung LY (2008) Antioxidant profiles of a prepared extract of Chinese herbs for the treatment of atopic eczema. Phytother Res 22(4):493–499. doi:10.1002/ptr.2350

    Article  PubMed  Google Scholar 

  53. Sheehan MP, Atherton DJ (1994) One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 130(4):488–493. doi:10.1111/j.1365-2133.1994.tb03383.x

    Article  CAS  PubMed  Google Scholar 

  54. Sheehan MP, Stevens H, Ostlere LS, Atherton DJ, Brostoff J, Rustin MHA (1995) Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year. Clin Exp Dermatol 20(2):136–140

    Article  CAS  PubMed  Google Scholar 

  55. Latchman YE, Xu XJ, Poulter LW, Rustin MHA, Atherton DJ, Brostoff J (2002) Chinese medical herbs in the treatment of atopic dermatitis. Allergy Clin Immunol Int 14(1):4–9

    Article  Google Scholar 

  56. TGA (2001) Aristolochia alert for practitioners. http://www.tga.gov.au/safety/alerts-medicine-aristolochia-010723.htm.

  57. Blackwell R (1996) Adverse events involving certain Chinese herbal medicines and the response of the profession. J Chin Med 50:12–22

    Google Scholar 

  58. Hon KLE, Leung TF, Wong Y, Lam WKC, Guan DQB, Ma KC, Sung YTR, Fok TF, Leung PC (2004) A pentaherbs capsule as a treatment option for atopic dermatitis in children: an open-labeled case series. Am J Chin Med 32(6):941–950. doi:10.1142/s0192415x04002545

    Article  PubMed  Google Scholar 

  59. Hon KLE, Leung TF, Ng PC, Lam MCA, Kam WYC, Wong KY, Lee KCK, Sung YT, Cheng KF, Fok TF, Fung KP, Leung PC (2007) Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 157(2):357–363. doi:10.1111/j.1365-2133.2007.07941.x

    Article  CAS  PubMed  Google Scholar 

  60. Hon KL, Lo W, Cheng WKF, Leung TF, Chow CM, Lau CBS, Fok TF, Ng PC, Leung PC (2012) Prospective self-controlled trial of the efficacy and tolerability of a herbal syrup for young children with eczema. J Dermatol Treat 23(2):116–121. doi:10.3109/09546634.2010.514893

    Article  Google Scholar 

  61. Leung TF, Wong KY, Wong CK, Fung KP, Lam CWK, Fok TF, Leung PC, Hon KLE (2008) In vitro and clinical immunomodulatory effects of a novel Pentaherbs concoction for atopic dermatitis. Br J Dermatol 158(6):1216–1223. doi:10.1111/j.1365-2133.2008.08502.x

    Article  CAS  PubMed  Google Scholar 

  62. Chan BCL, Hon KLE, Leung PC, Sam SW, Fung KP, Lee MYH, Lau HYA (2008) Traditional Chinese medicine for atopic eczema: pentaherbs formula suppresses inflammatory mediators release from mast cells. J Ethnopharmacol 120(1):85–91. doi:10.1016/j.jep.2008.07.034

    Article  PubMed  Google Scholar 

  63. Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, Kusunoki T, Furue M (2010) Efficacy and safety of a traditional herbal medicine, hochu-ekki-to in the long-term management of Kikyo (Delicate Constitution) patients with atopic dermatitis: A 6-month, multicenter, double-blind, randomized, placebo-controlled study. Evid Based Complement Alternat Med 7(3):367–373. doi:10.1093/ecam/nen003

    Article  PubMed  Google Scholar 

  64. Nakada T, Watanabe K, Matsumoto T, Santa K, Triizuka K, Hanawa T (2002) Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen. Int Immunopharmacol 2(7):901–911. doi:10.1016/s1567-5769(02)00027-9

    Article  CAS  PubMed  Google Scholar 

  65. Cheng HM, Chiang LC, Jan YM, Chen GW, Li TC (2011) The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol 155(2):141–148. doi:10.1159/000318861

    Article  PubMed  Google Scholar 

  66. Scheid V, Bensky D, Ellis A, Barolet R (2009) Chinese herbal medicine formulas and strategies, 2nd edn. Eastland Press, Seattle

    Google Scholar 

  67. Shichijo K, Saito H (1997) Effect of Chinese herbal medicines and disodium cromoglycate on IgE- dependent histamine release from mouse cultured mast cells. Int J Immunopharmacol 19(11–12):677–682. doi:10.1016/s0192-0561(97)00097-0

    CAS  PubMed  Google Scholar 

  68. Bansal D, Hota D, Chakrabarti A (2010) Research methodological issues in evaluating herbal interventions. Open Access J Clin Trials 2:15–21

    Google Scholar 

  69. Cardini F, Wade C, Regalia AL, Gui S, Li W, Raschetti R, Kronenberg F (2006) Clinical research in traditional medicine: priorities and methods. Complement Ther Med 14(4):282–287. doi:10.1016/j.ctim.2006.07.003

    Article  PubMed  Google Scholar 

  70. Carter B (2003) Methodological issues and complementary therapies: researching intangibles? Complement Ther Nurs Midwifery 9(3):133–139. doi:10.1016/s1353-6117(03)00042-8

    Article  PubMed  Google Scholar 

  71. Yuan R, Lin Y (2000) Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther 86(2):191–198. doi:10.1016/s0163-7258(00)00039-5

    Article  CAS  PubMed  Google Scholar 

  72. Kobayashi M, Davis SM, Utsunomiya T, Pollard RB, Suzuki F (1999) Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza a2 virus infection in mice. Am J Chin Med 27(1):53–62

    Article  CAS  PubMed  Google Scholar 

  73. Byard RW (2010) A review of the potential forensic significance of traditional herbal medicines. J Forensic Sci 55(1):89–92. doi:10.1111/j.1556-4029.2009.01252.x

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George Binh Lenon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Tan, H.Y., Lenon, G.B. (2016). Atopic Dermatitis and Chinese Medicine. In: Inui, A. (eds) Herbal Medicines. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-4002-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-4002-8_9

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-4000-4

  • Online ISBN: 978-1-4939-4002-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics